Cancer news

Latest news, press releases and blog posts from Cancer Research UK.

News Post List

News digest – breast screening error, gene tests, childhood obesity and mobile phones

This week’s top story: Around 450,000 women in England weren’t invited for their final breast screening appointment due to an error with NHS computers.

Breast screening error: women need reassurance, not misleading statistics

In the immediate aftermath, estimating the numbers affected by a breast screening error might do more harm than good.

Vigorous exercise reduces tiredness in testicular cancer survivors

High intensity interval training reduces tiredness and improves self-esteem for testicular cancer survivors.

Press release links rise in aggressive brain tumours to mobile phones, but study doesn’t

Headlines today have linked mobile use to brain tumours, but the claims don't match the study they're covering.

Dr Iain Frame appointed CEO of the National Cancer Research Institute

Dr Iain Frame has been appointed as the new CEO of the National Cancer Research Institute (NCRI).

450,000 women missed out on breast screening appointments 'due to computer error'

Around 450,000 women in England missed out on a routine breast screening appointment due to an NHS failure to send invitations.

A better understanding of brain tumour biology will bring new treatments

Brain tumour researchers face many challenges that are holding up progress. Find out how we’re bringing scientists together to overcome them.

£18 million fund to tackle six biggest themes in brain tumour research launched today

The Cancer Research UK Brain Tumour Awards* have been launched in partnership with The Brain Tumour Charity today.

Cancer Research UK appoints new chief executive

Michelle Mitchell OBE has been appointed as CEO of Cancer Research UK, replacing Sir Harpal Kumar who is due to stand down in the summer.

Gene test might benefit women with hard-to-treat breast cancer

Aggressive breast cancers carrying a faulty BRCA gene responded better to a certain type of chemotherapy than standard treatment, according to a trial.